ArticleViruses2024

Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin's Lymphoma: A Single-Center Cohort Study.

Makoto Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.